SCHEMBL29598524

SCHEMBL29598524

Cc1cc(Cl)cc2c(=O)oc(-c3cc(Br)nn3-c3ncccc3Cl)nc12

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 3/20 0.43
▸ CYP17A1 P05093 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ MAPT P10636 2/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ MALT1 Q9UDY8 1/20 0.31
▸ TRPV1 Q8NER1 2/20 0.31
▸ ELANE P08246 1/20 0.30
▸ FABP3 P05413 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30
▸ CYP2D6 P10635 1/20 0.30
▸ CYP2C9 P11712 1/20 0.30
▸ FABP4 P15090 1/20 0.30
▸ FABP5 Q01469 1/20 0.30
▸ ABL1 P00519 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL465839 1.00 DHODH (0.43) DHODHCYP17A1CYP1A2MAPTALDH1A1
SCHEMBL28531289 0.96 DHODH (0.41) DHODHCYP17A1CYP1A2MAPTALDH1A1
SCHEMBL29215063 0.93 DHODH (0.36) DHODHMAPTELANEFABP3CYP3A4
SCHEMBL21822337 0.93 DHODH (0.43) DHODHCYP17A1CYP1A2MAPTTRPV1
SCHEMBL12528168 0.93 DHODH (0.43) DHODHCYP17A1CYP1A2MAPTALDH1A1
SCHEMBL30560159 0.93 DHODH (0.43) DHODHCYP17A1CYP1A2MAPTTRPV1
SCHEMBL30466603 0.92 DHODH (0.44) DHODHCYP17A1CYP1A2TRPV1
SCHEMBL959396 0.92 DHODH (0.44) DHODHCYP17A1CYP1A2TRPV1
SCHEMBL950250 0.91 DHODH (0.40) DHODHMAPTALDH1A1POLBNPSR1
SCHEMBL30749778 0.91 DHODH (0.40) DHODHMAPTALDH1A1POLBNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3902792-B1 PROCESS FOR PREPARATION OF ANTHRANILAMIDES UPL LTD (IN) 2025-05-21 — — EP claimed
CN-116535388-B Chlorantraniliprole Process for the preparation of amides 江苏七洲绿色科技研究院有限公司 2024-12-10 — — CN disclosed
US-20240327395-A1 A PROCESS FOR PREPARING BENZOXAZINONE COMPOUNDS TAGROS CHEMICALS INDIA PVT LTD (IN) 2024-10-03 — — US disclosed
CN-117700393-A Preparation method of chlorantraniliprole 青岛科技大学 2024-03-15 — — CN disclosed
CN-117551091-A Synthetic method of chlorantraniliprole and intermediate thereof 青岛润农化工有限公司 2024-02-13 — — CN disclosed
US-20230382887-A1 PROCESS FOR THE PREPARATION OF CHLORANTRANILIPROLE GHARDA CHEMICALS LIMITED (IN) 2023-11-30 — — US disclosed
US-20230312508-A1 IMPROVED PROCESS FOR PREPARATION OF ANTHRANILAMIDES GSP CROP SCIENCE PRIVATE LIMITED (IN) 2023-10-05 — — US disclosed
EP-4232442-A1 A PROCESS FOR THE PREPARATION OF CHLORANTRANILIPROLE Gharda Chemicals Limited (IN) 2023-08-30 — — EP disclosed
EP-3632911-B1 METHOD FOR PREPARING ISOXAZINONE COMPOUND AND APPLICATION THEREOF ZHEJIANG ZHUJI UNITED CHEMICALS CO LTD (CN) 2023-08-09 — — EP disclosed
CN-116529239-A Process for preparing chlorantraniliprole 格哈达化工有限公司 2023-08-01 — — CN disclosed
CN-112574190-B Method for synthesizing chlorantraniliprole 江苏快达农化股份有限公司 2022-11-11 — — CN disclosed
CN-112574190-B Method for synthesizing chlorantraniliprole 江苏快达农化股份有限公司 2022-11-11 — — CN disclosed
CN-111423431-B Preparation method of chlorantraniliprole and intermediate thereof 利尔化学股份有限公司 2022-10-28 — — CN disclosed
CN-111423431-B Preparation method of chlorantraniliprole and intermediate thereof 利尔化学股份有限公司 2022-10-28 — — CN disclosed
CN-217527484-U Production device of benzoxazinone 山东友道化学有限公司 2022-10-04 — — CN disclosed
WO-2022136931-A1 IMPROVED PROCESS FOR PREPARATION OF ANTHRANILAMIDES GSP CROP SCIENCE PRIVATE LIMITED (IN) 2022-06-30 — — WO disclosed
WO-2022084887-A1 A PROCESS FOR THE PREPARATION OF CHLORANTRANILIPROLE GHARDA CHEMICALS LIMITED (IN) 2022-04-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230382887-A1 PROCESS FOR THE PREPARATION OF CHLORANTRANILIPROLE NPEPPS, PRLHR, ADCYAP1R1 DHODH 641/4885CYP17A1 951/4885CYP1A2 535/4885
US-20230312508-A1 IMPROVED PROCESS FOR PREPARATION OF ANTHRANILAMIDES NAAA, AADAC, CYCS DHODH 1635/4885CYP17A1 2228/4885CYP1A2 179/4885
US-20240327395-A1 A PROCESS FOR PREPARING BENZOXAZINONE COMPOUNDS XDH, PDHX, CYP11B1 DHODH 1384/4885CYP17A1 24/4885CYP1A2 55/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback